P213: High prevalence and risk factors for nonalcoholic fatty liver disease in patients with Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: FloresM.D.PhD, C.(1)*;Souza, R.K.(1);De Bona, L.R.(2);Deconto, M.D.(3);Arrojo, R.S.(4);Gazzoni, F.F.(5);Oliveira, T.F.(6);
(1)Universidade Federal do Rio Grande do Sul, Graduate degree program of Gastroenterology and Hepatology, Porto Alegre, Brazil;(2)Hospital de Clínicas de Porto Alegre, Pesquisa Clínica, Porto Alegre, Brazil;(3)Universidade Luterana do Brasil, Faculdade de medicina, Porto Alegre, Brazil;(4)Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Porto Alegre, Brazil;(5)Hospital de Clínicas de Porto Alegre, Serviço de Radilogia, Porto Alegre, Brazil;(6)Universidade Federal de Ciências da Saúde de Porto Alegre, Farmacociências, Porto Alegre, Brazil;
P214: Cine MRI assessment of colonic motility in patients with ulcerative colitis associated constipation.ECCO’23 CopenhagenYear: 2023
Authors: Miller, C.(1)*;Taylor, S.(2);Emmanuel, A.(1);Zarate-Lopez, N.(1);Pakpoor, J.(2);Fitzke, H.(3);Menys, A.(3);Holmes, J.(3);Atkinson, D.(3);Markus, J.(3);Blad, W.(1);Bloom, S.(1);
(1)University College Hospital, Gastroenterology Department, London, United Kingdom;(2)University College Hospital, Radiology Department, London, United Kingdom;(3)University College London, Radiology Department, London, United Kingdom;
P215: Deep immune phenotyping of unconventional T cells reveals a depletion in Mucosa Associated T Cells (MAIT) in IBD patients with extraintestinal manifestationsECCO’23 CopenhagenYear: 2023
Authors: Catalàn-Serrax, I.(1,2,3)*;Xu, W.(4);Bruland, T.(5);Larbi, A.(6);Sandvik, A.K.(5,7,8);
(1)Levanger Hospital- Nord-Trondelag Hospital Trust., Department of Gastroenterology, Levanger, Norway;(2)Centre of Molecular Inflammation Research- NTNU-Norwegian University of Science and Technology, Cemir, Trondheim, Norway;(3)Norwegian University of Science and Technology NTNU, Department of Clinical and Molecular Medicine IKOM, Trondheim, Norway;(4)Agency for Science Technology and Research, Singapore Immunology Network SIgN, Singapore, Singapore;(5)Norwegian University of Science and Technology, Department of Clinical and Molecular Medicine IKOM, Trondheim, Norway;(6)Agency for Science Technology and Research, Agency for Science Technology and Research, Singapore, Singapore;(7)Centre of Molecular Inflammation Research, Cemir, Trondheim, Norway;(8)St. Olav's University Hospital, Department of Gastroenterology and Hepatology- Clinic of Medicine, Trondheim, Norway;
P216: Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocecal resection for Crohn's disease: a retrospective analysis of 853 consecutive patients treated in a tertiary centre.ECCO’23 CopenhagenYear: 2023
Authors: Dajti, G.(1);Cardelli, S.(1);Rizzello, F.(2);Gionchetti, P.(2);Poggioli, G.(1);Rottoli, M.(1)*;
(1)IRCCS Azienda Ospedaliero Universitaria di Bologna- Alma Mater Studiorum University of Bologna, Surgery of the Alimentary Tract, Bologna, Italy;(2)IRCCS Azienda Ospedaliero Universitaria di Bologna- Alma Mater Studiorum University of Bologna, IBD Unit, Bologna, Italy;
P217: Volatile organic metabolites to predict clinical response to biological therapy in inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Ribaldone, D.G.(1)*;Arezzo, A.(2);Cardenia, V.(3);Caviglia, G.P.(4);Abate, M.L.(4);Saracco, G.M.(4);Astegiano, M.(5);Morino, M.(4);
(1)University of Turin, Department of Mediical Sciences, Turin, Italy;(2)University of Turin, Department of Surgical Sciences, Turin, Italy;(3)University of Torino, Department of Forestry- Agriculture and Food Sciences, Turin, Italy;(4)University of Turin, Department of Medical Sciences, Turin, Italy;(5)Molinette Hospital, Unit of Gastroenterology, Turin, Italy;
P218: It is time to grow up: readiness is associated with better outcomes in a prospective study of pediatric transition patients with Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Nardone, O.M.(1)*;Martinelli, M.(2);De sire, R.(3);Calabrese, G.(3);Caiazzo, A.(3);Fioretti, M.T.(2);Testa, A.(3);Limansky, L.(3);Rispo, A.(3);Di Luna, I.(3);Miele, E.(2);Staiano, A.(2);Castiglione, F.(3);
(1)University Federico II of Naples, Gastroenterology- Department of Public Health, Naples, Italy;(2)University Federico II of Naples, Section of Pediatrics-Department of Translational Medical Science, Naples, Italy;(3)University Federico II of Naples, Gastroenterology- Department of Clinical Medicine and Surgery, Naples, Italy;
P219: Migraine Is Associated with the Development of Inflammatory Bowel Disease: A Nationwide, Population-Based StudyECCO’23 CopenhagenYear: 2023
Authors: Lee, C.(1)*;Han, K.(2);Yu, H.(1);Kim, S.(1);Choi, K.(1);Lee, H.J.(1);Koh, S.J.(1);Im, J.P.(1);Kim, J.S.(1);
(1)Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul- Korea, Korea- Republic Of;(2)Soongsil University, Department of Statistics and Actuarial Science, Seoul- Korea, Korea- Republic Of;
P220: Patient's disease perception and health-related quality of life with IBD: Results from a Spanish cohort with 15 years of follow upECCO’23 CopenhagenYear: 2023
Authors: Elosua Gonzalez, A.(1)*;Rubio, S.(2);Irisarri, R.(2);Campillo, A.(3);Nantes, Ó.(2);Vicuña, M.(2);Angós, R.(4);Zozaya, J.M.(2);Rodríguez, C.(2);
(1)Hospital García Orcoyen, Gastroenterology, Estella, Spain;(2)Hospital Universitario de Navarra, Gastroenterology, Pamplona, Spain;(3)Hospital Reina Sofía, Gastroenterology, Tudela, Spain;(4)Clínica Universidad de Navarra, Gastroenterology, Pamplona, Spain;
P221: Validity of the Self-administered Comorbidity Questionnaire in patients with Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Van Linschoten, R.(1,2,3)*;Huberts, A.S.(4);van Leeuwen, N.(2);Hazelzet, J.A.(2);van der Woude, C.J.(3);West, R.L.(5);van Noord, D.(5);
(1)Franciscus Gasthuis & Vlietland, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(2)Erasmus MC, Department of Public Health, Rotterdam, The Netherlands;(3)Erasmus MC, Department of Gastroenterology & Hepatology, Rotterdam, The Netherlands;(4)Erasmus MC, Department of Quality and Patientcare, Rotterdam, The Netherlands;(5)Franciscus Gasthuis & Vlietland, Department of Gastroenterology & Hepatology, Rotterdam, The Netherlands;On behalf of the Southwest Netherlands IBD Study Group
P223: The usefulness of tissue calprotectin in pediatric Crohn's disease – a pilot study.ECCO’23 CopenhagenYear: 2023
Authors: Szymanska, E.(1)*;Szymanska, S.(2);Karkucinka-Wieckowska, A.(3);Aldona, W.(4);Kierkus, J.(5);Dadalski, M.(6);
(1)Children's Memorial Health Institute, Department of Gastroenterology- Hepatology- Feeding Disorders and Pediatrics, Warsaw, Poland;(2)Children's Memorial Health Institute, Pathomorphology, Warsaw, Poland;(3)Children's Memorial Health Institute-, Pathomorphology, Warsaw, Poland;(4)Children's Memorial Health Institute, Department of Biochemistry and Experimental Medicine-, Warsaw, Poland;(5)The Children's Memorial Health Institute- Warsaw- Poland, Department of Gastroenterology- Hepatology- Feeding Disorders and Pediatrics, Warsaw, Poland;(6)Children's Memorial Health Institute, Department of Gastroenterology- Hepatology- Feeding Disorders and Pediatrics-, Warsaw, Poland;Biomarkers inflammatory bowel disesae elafin
P224: Diagnostic delay in inflammatory bowel disease is not associated with difficult access to healthcare facilities: a clinical study on incidental casesECCO’23 CopenhagenYear: 2023
Authors: Cantoro, L.(1)*;Monterubbianesi, R.(1);Camastra, C.(1);Falasco, G.(1);Pantanella, P.(1);Cosintino, R.(1);Faggiani, R.(1);Fiorino, G.(1,2);
(1)Azienda Ospedaliera San Camillo-Forlanini, IBD Unit- Department of Gastroenterology and Digestive Endoscopy, Rome, Italy;(2)Vita e Salute University, Gastroenterology and Digestive Endoscopy, Milan, Italy;
P225: The accuracy of different intestinal ultrasound parameters in detecting endoscopic activity in patients with inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: KatsarosMD, M.(1)*;Palmela, C.(2);Kalogirou, M.(1);Frias Gomes, C.(2);Katsoula, A.(1);Torres, J.(2);Giouleme, O.(1);
(1)Hippokration Hospital, Gastroenterology Division- Second Propaedeutic Department of Internal Medicine- Medical School- Aristotle University of Thessaloniki, Thessaloniki, Greece;(2)Hospital Beatriz Ângelo, Department of Gastroenterology, Loures, Portugal;
P226: Dietary patterns differ in the newly diagnosed IBD cohort with ethnicity as a key confounding variable, a case control studyECCO’23 CopenhagenYear: 2023
Authors: Dyall, L.(1)*;Kyle, J.(2);Misra, R.(3);Clark, H.(4);Limdi, J.(5);Cooney, R.(6);Brookes, M.(7);Fogden, E.(8);Pattni, S.(9);Sharma, N.(10);Iqbal, T.(6);Munkholm, P.(11);Burisch, J.(11);Arebi, N.(3);
(1)St Mark's Hospital and Academic Institute- London- United Kingdom, Inflammatory Bowel Diseases, Slough, United Kingdom;(2)University of Aberdeen, Institute of Applied Health Sciences, Aberdeen, United Kingdom;(3)St Mark's Hospital and Academic Institute, Inflammatory Bowel Disease, London, United Kingdom;(4)University of Aberdeen, Institute of Applied Health Sciences, Abderdeen, United Kingdom;(5)Northern Care Alliance NHS Foundation Trust, Institute of Inflammation and Repair, Manchester, United Kingdom;(6)University Hospitals Birmingham, Gastroenterology, Birmingham, United Kingdom;(7)Royal Wolverhampton NHS Trust, Gastroenterology, Wolverhampton, United Kingdom;(8)Sandwell and West Birmingham Hospitals, Gastroenterology, Birmingham, United Kingdom;(9)University Leicester Hospitals, Gastroenterology, Leicester, United Kingdom;(10)Heartlands Hospital, Gastroenterology, Birmingham, United Kingdom;(11)North Zealand University Hospital, Gastroenterology, Frederikssund, Denmark;
P227: Patient experiences in ulcerative colitis: conceptual model and review of patient-reported outcome measuresECCO’23 CopenhagenYear: 2023
Authors: Kim, C.(1)*;Brown, F.L.(2);Burk, C.(3);Anatchkova, M.(4);Sargalo, N.(2);Kaushik, A.(1);
(1)Gilead Sciences, Health Economics and Outcomes Research, Foster City, United States;(2)Evidera, Patient Centered Research, London, United Kingdom;(3)HEOR Consultant, Health Economics and Outcomes Research, Laguna Beach, United States;(4)Evidera, Patient Centered Research, Bethesda, United States;
P228: Machine learning models utilizing simple laboratory tests may assess endoscopic activity in ulcerative colitisECCO’23 CopenhagenYear: 2023
Authors: Kempinski, R.(1)*;Kraszewski, S.(2);Nizioł, P.(3);Neubauer, K.(4);
(1)Wroclaw Medical University, Gastroenterology and Hepatology, Wroclaw, Poland;(2)Wroclaw University of Science and Technology, Department of Biomedical Engineering- Faculty of Fundamental Problems of Technology, Wroclaw, Poland;(3)Wroclaw University of Science and Technology, Faculty of Mechanical Engineering, Wrocław, Poland;(4)Wroclaw Medical University, Gastroenterology and Hepatology, Wrocław, Poland;
P229: Comparison of the characteristics of segmental mucosal microbiome according to the extent of inflammation in ulcerative colitis.ECCO’23 CopenhagenYear: 2023
Authors: Shin, J.(1)*;Kim, S.Y.(1);Kwon, D.(1);Cha, B.(1);Kong, S.M.(2);Kim, J.S.(3);Kwon, K.S.(1);Kim, H.(1);
(1)Inha University School of Medicine, Division of Gastroenterology- Department of Internal Medicine, Incheon, Korea- Republic Of;(2)Samsung Changwon Hospital- Sungkyunkwan University School of Medicine, Department of Medicine, Changwon, Korea- Republic Of;(3)Incheon National University, Department of Nano-Bioengineering, Incheon, Korea- Republic Of;
P230: Adalimumab in Crohn's disease is protective against periodontitis based on a validated oral health questionnaireECCO’23 CopenhagenYear: 2023
Authors: Saravanapavan, H.(1,2)*;Rath, S.(1,2);Inniss, S.(1,2);Ong, M.(1);Sabalić, M.(3);D'Aiuto, F.(3);Rahman, F.(1,2);Smith, A.M.(1);
(1)University College London, Microbial Diseases- Eastman Dental Institute, London, United Kingdom;(2)University College London Hospital, Department Gastroenterology, London, United Kingdom;(3)University College London, Periodontology Unit- UCL Eastman Dental Institute and Hospital, London, United Kingdom;
P231: Impact of age of Inflammatory Bowel Disease diagnosis on disease phenotype and severity in elderly patientsECCO’23 CopenhagenYear: 2023
Authors: Orfanoudaki, E.(1)*;Chlorakis, G.(1);Foteinogiannopoulou, K.(1);Drygiannakis, I.(1);Theodoraki, E.(1);Tsafaridou, M.(1);Koutroubakis, I.(1);
(1)University Hospital of Heraklion- Medical School- University of Crete, Gastroenterology, Heraklion- Crete, Greece;
P232: Serum neutrophil gelatinase associated lipocalin (NGAL) as a marker of activity of Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Ali, K.(1);Bahgat, M.(1);Borg, A.(2);Maher, M.(1);Abozeid, F.(1)*;
(1)Mansoura university, Internal medicine, Mansoura, Egypt;(2)Mansoura university, clinical pathology, Mansoura, Egypt;
